Targeted Nanobubbles of PD-L1 mAb Combined with Doxorubicin as a Synergistic Tumor Repressor in Hepatocarcinoma
Yezi Chen,1,2,* Xiaoqin Luo,2,3,* Yun Liu,4 Yunlei Zou,1,2 Shiqi Yang,1,2 Chaoqi Liu,1,2 Yun Zhao1,2 1Hubei Key Laboratory of Tumor Microenvironment and Immunotherapy, China Three Gorges University, Yichang, People’s Republic of China; 2Medical College of China Three Gorges Universit...
Main Authors: | Chen Y, Luo X, Liu Y, Zou Y, Yang S, Liu C, Zhao Y |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2022-09-01
|
Series: | International Journal of Nanomedicine |
Subjects: | |
Online Access: | https://www.dovepress.com/targeted-nanobubbles-of-pd-l1-mab-combined-with-doxorubicin-as-a-syner-peer-reviewed-fulltext-article-IJN |
Similar Items
-
Doxorubicin-Loaded Platelet Decoys for Enhanced Chemoimmunotherapy Against Triple-Negative Breast Cancer in Mice Model
by: Dong H, et al.
Published: (2023-06-01) -
Evading Doxorubicin-Induced Systemic Immunosuppression Using Ultrasound-Responsive Liposomes Combined with Focused Ultrasound
by: Jeongjin Lee, et al.
Published: (2022-11-01) -
Sustained and Long-Term Release of Doxorubicin from PLGA Nanoparticles for Eliciting Anti-Tumor Immune Responses
by: Jeongrae Kim, et al.
Published: (2022-02-01) -
All-in-one glycol chitosan nanoparticles for co-delivery of doxorubicin and anti-PD-L1 peptide in cancer immunotherapy
by: Sukyung Song, et al.
Published: (2023-10-01) -
Biocompatible Chitosan Nanobubbles for Ultrasound-Mediated Targeted Delivery of Doxorubicin
by: Xiaoying Zhou, et al.
Published: (2019-01-01)